Authors
Latest:
Focusing pharma marketing on 'headroom'In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'
Latest:
A Process-Based Approach To Aggregate SpendA Process-Based Assessment (PBA) is the first step to analyzing reporting needs
Latest:
A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trendsVaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations
Latest:
Regulatory Focus on Off-Label Promotion Is RisingWhile FDA guidance on appropriate medical communication has evolved, US Dept. of Justice attention the practice is intensifying
Latest:
Effective and proactive oversight of master dataGo-to safeguards for manufacturers in avoiding mismanagement of their business-central records
Latest:
Big Pharma requires big help in protecting CRT productsAn inside look at selection and implementation of passive thermal protection
Latest:
With coupons, pharma is saying 'Let's make a deal' to consumersPharma marketers become adept at refining coupon and voucher programs, while technology options multiply. Meanwhile payer criticism mounts
Latest:
NCPDP Standards for Accurate Billing, Reimbursement and AccessThe National Council for Prescription Drug Programs’ (NCPDP) Billing Unit Standard (BUS) brings order to pharmaceutical transactions. Between it, the National Drug Code (NDC) and the Structured Product Label (SPL), all necessary commercial information about a product is known.
Latest:
Preparing the Market for a New Drug with an Effective 'Medical Affairs Launch'The Medical Affairs function can play a vital role in today’s product launch process
Latest:
How tackling counterfeit drugs will drive improvements in the pharma supply chainBig Data and AI will bring value beyond compliance
Latest:
The Rise of 'Companion' Diagnostics for Specialty PharmaceuticalsUnder the theme of personalized medicine, in vitro diagnostics will play an increasingly important role in new drug entries and new therapies
Latest:
Precision medicine and the importance of dataPatient-support Hub services are a vital repository of the patient journey
Latest:
Data security for PharmaCloud computing opens a new array of benefits--and challenges--to data-sharing
Latest:
Ensuring the quality of comparative effectiveness researchAs payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical
Latest:
Economic Considerations For REMSDrug sponsors have options in both how the new FDA risk programs are structured and how to execute them
Latest:
Recent US Supreme Court decisions narrow life-sciences patentability claimsIndustry response may be to keep more innovations as trade secrets
Latest:
Prilenia Announces Plans to Initiate Global Phase III Study of Novel ALS TreatmentData from prior Phase II study showed signs of pridopidine slowing disease progression in patients with amyotrophic lateral sclerosis.
Latest:
How Packaging and Delivery Technologies Influence the Commercialization of Injectable DrugsOften mistakenly considered an afterthought, today’s packaging and delivery systems can powerfully affect the safety, efficacy and commercial success of injectables
Latest:
Preparing the Market for a New Drug with an Effective 'Medical Affairs Launch'The Medical Affairs function can play a vital role in today’s product launch process
Latest:
Specialty drugs are generating a new paradigm: Commercial InnovationSpecialty drug market success requires patient-focused and therapy-specific channel and services strategies
Latest:
Get better at managing clinical trial financialsControl of costs and accounting during clinical trials is a well-known challenge to sponsors. Tools are available
